DS Core Detect
Dentsply Sirona, Inc. · Decision date Oct 30, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for K261072, DS Core Detect, on October 30, 2026, with Dentsply Sirona, Inc. as applicant. The device is a cloud-based computer assisted detection software intended to aid licensed dentists in incidental detection of permanent teeth that may be associated with periapical radiolucencies in existing CBCT images; it does not generate X-ray images. The public record lists regulation 21 CFR 892.2070, product code MYN, and specialty Radiology.
The submission states the subject device is identical to predicate DS Core Detect (K253009) except for an authorized Predetermined Change Control Plan V1.0, described as the sole distinguishing feature; no additional performance testing was conducted. SESE here is a 510(k) clearance, not PMA approval. The record does not disclose PCCP modification specifics, and the two pages give conflicting receipt dates (September 28, 2026 in the letter versus April 1, 2026 in the database).
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Radiology
- Decision date
- Oct 30, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261072
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Dentsply Sirona, Inc.
- Product code
- MYN
- Decision code
- SESE
- Decision date
- Oct 30, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Analyzer, Medical Image.
- Applicant
- Dentsply Sirona, Inc.
- Product code
- MYN
- FDA device class
- 2
FDA decision timeline
K261072 received
Application receipt date recorded by FDA.
K261072 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code MYN
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
ChestView US (1.1)K252486 | Gleamer | 510(k) clearance | Sep 9, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Dentsply Sirona, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- York, PA
Sources and methodology
- Original FDA record: K261072
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records